PAX3 and neoplasm: We therefore conducted a proteomic analyses of ARMS to characterize the protein profile associated with PAX3-FOXO1 fusion with cross-reference to the gene expression data, with the aim of identifying efficient therapeutic targets in this tumor that could be treated using easy methods of administration (i.e., oral administration).